Early drug combo shows promise for high-risk leukemia patients
Disease control
Completed
This study tested whether the drug ibrutinib, given with vaccines, can help people with early-stage but high-risk chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) live longer without their cancer getting worse. The trial included 42 participants who had not …
Phase: PHASE2 • Sponsor: Jennifer Woyach • Aim: Disease control
Last updated May 13, 2026 15:59 UTC